The Norwegian COVID-19, Mental Health and Adherence Project (MAP-19) project is a large-scale longitudinal epidemiological investigation examining mental health during the COVID-19 pandemic.

About the Project

The study particularly examines the connection between non-pharmacological interventions (NPIs) employed against the SARS CoV-2 virus and mental health symptoms in the general adult population.

The project further investigates the role of personality, contextual factors, and psychological mechanisms in relation to vaccine hesitancy and adherence to viral mitigation behaviours.

The project is initiated and led by the three University of Oslo and Modum Bad Psychiatric Hospital Researchers, Omid V. Ebrahimi, Sverre Urnes Johnson and Asle Hoffart. It has been featured widely in the international pandemic literature, across national news platforms, and has been central in the understanding the mental health sequelae related to the pandemic.

Objectives

The MAP-19 project aims to:

Monitor mental health in the general adult population across the pandemic period.

Provide a foundation for policymakers and health-care professionals to employ interventions that protect the general public against psychological stressors accompanying the pandemic.

Help policymakers better understand the associations of demographic variables and psychological symptoms with adherence to viral mitigation behaviours, providing an understanding of adherence rates and its central covariates to help society fight against the COVID-19-virus by finding actionable targets that facilitate adherence viral mitigations behaviours.

Investigate the mental health status in vulnerable and at-risk subgroups in the population during the COVID-19 pandemic, including health-care professionals, politicians, and social workers.​

Inform policymakers, the general public, scientists, and health practitioners about the psychological implications tied to the COVID-19-related government-initiated measures.

Results so far

The MAP-19 project has resulted in more than 30 peer-reviewed international publications to date. Some of these studies include:

• Study 1
• Study 2
• Study 3
• Study 4
• Study 5
• Study 6
• Study 7
• Study 8
• Study 9
• Study 10
• Study 11
• Study 12
• Study 13
• Study 14
• Study 15
• Study 16
• Study 17
• Study 18
• Study 19
• Study 20
• Study 21
• Study 22
• Study 23
• Study 24
• Study 25
• Study 26
  

Collaboration

The MAP-19 Study is in active collaboration with the COVIDMENT research group at University of Iceland, Karolinska Institutet, University of Bergen, The Norwegian Public Health Institute, Rigshospitalet in Copenhagen, and University of Tartu.

Funding

The project is a dual competency project i.e. a collaboration between Modum Bad and the University of Oslo, Institute of Psychology, department of clinical psychology. The research project is funded by University of Oslo and the clinical specialization is funded by Modum Bad.

Contact Information

Sverre Urnes Johnson, CO-PI of The MAP-19 Study

Omid V. Ebrahimi, CO-PI of The MAP-19 Study

Asle Hoffart, CO-PI of The MAP-19 Study

You can also reach us through the Modum Bad telephone service: 32 74 97 00.

Project team at Modum Bad

Project participants

• Sverre Urnes Johnson, CO-PI of The CIPA Study
• Omid V. Ebrahimi, CO-PI of The CIPA Study
• Asle Hoffart, Project Group of The CIPA Study

Publications